SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
SEC Accession No. 0001493526-12-000009
Filing Date
2012-05-17
Accepted
2012-05-17 15:54:46
Documents
11
Period of Report
2011-12-31
Filing Date Changed
2012-05-17

Document Format Files

Seq Description Document Type Size
1 dec1110kprotectedgar.htm 10-K 792755
2 exhibit311.htm EX-31 5623
3 exhibit312.htm EX-31 5653
4 exhibit321.htm EX-32 3978
5 exhibit322.htm EX-32 4217
  Complete submission text file 0001493526-12-000009.txt   1898349

Data Files

Seq Description Document Type Size
6 prtt-20111231.xml EX-101.INS 180143
7 prtt-20111231.xsd EX-101.SCH 9616
8 prtt-20111231_cal.xml EX-101.CAL 6024
9 prtt-20111231_def.xml EX-101.DEF 40796
10 prtt-20111231_lab.xml EX-101.LAB 76324
11 prtt-20111231_pre.xml EX-101.PRE 57946
Mailing Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109
Business Address 2681 EAST PARLEYS WAY SUITE 204 SALT LAKE CITY UT 84109 8013223401
PROTECT PHARMACEUTICAL Corp (Filer) CIK: 0001493526 (see all company filings)

IRS No.: 271877179 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54001 | Film No.: 12851926
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1